India Patent Cases
2,823 decisions indexed
Page 17 of 95 · 2,823 total
Koninklijke Philips Electronics N.V. v.Maj(Retd) Sukesh Behl & Anr
Koninklijke Philips Electronics N.V. initiated legal proceedings against Maj(Retd) Sukesh Behl and others concerning a Suit Patent related to an 8/16 modulation method used in data recording on discs. The court addressed complex issues, including the patent's validity under various sections of the Patents Act (such as novelty, sufficiency of disclosure, and non-patentability). Ultimately, after analyzing infringement claims and the defendants' conduct, the judgment focused on determining appropriate FRAND royalty rates for the patented technology.
Evonik Operations Gmbh And Anr v.The Controller Of Patents And Designs And Anr.
This appeal was filed by Evonik Operations Gmbh challenging an order dated May 2, 2023, which rejected Patent Application No. 201837000665. The court directed the appellants to file an Informal Paper Book and listed the matter for April 2025.
UPL Limited v.Astec Lifeciences Limited And Anr
The appeal challenged an earlier pre-grant objection order passed under Section 25 of the Patents Act, 1970. The court found that the impugned order suffered from a gross violation of natural justice due to its mechanical and verbatim reproduction of the private respondent's submissions without independent application of mind. Consequently, the court set aside the order and remanded the matter.
Tahoe Research Ltd. v.The Controller of Patents
Tahoe Research Ltd appealed the rejection of its patent application (No. 201647014734) by The Controller of Patents. The appellant argued that principles of natural justice were violated regarding lack of clarity objections, and that the novelty analysis incorrectly applied EPO reasoning without considering material differences in the claims.
F Hoffmann-La Roche Ltd & Others v.Drugs Controller General of India & Others
The plaintiffs, innovators of biological drugs 'bevacizumab' (AVASTIN) and 'trastuzumab' (HERCEPTIN), filed suits against generic manufacturers (Hetero and Cadila) seeking permanent injunctions. The current judgment addresses applications for the disclosure and production of documents related to the defendants' regulatory approvals, arguing that the approvals were obtained by suppressing material facts.
F Hoffmann-La Roche Ltd v.Drugs Controller General Of India
The plaintiffs, innovators of biological cancer drugs 'bevacizumab' (AVASTIN) and 'trastuzumab' (HERCEPTIN), filed suits against the Drugs Controller General of India and associated defendants. The current judgment addresses applications seeking disclosure and production of documents related to the DCGI approvals granted to bio-similar versions of these drugs.
Vgx Pharmaceuticals Inc v.The Controller General Of Patents, Designs And Trademarks
Vgx Pharmaceuticals Inc challenged the refusal of its patent application concerning 'Electroporation Devices and Methods.' The appeal argued that the Assistant Controller's order was unreasoned, failing to provide a clear justification for rejecting the invention based on prior art D4 and D5. The Delhi High Court agreed, finding the impugned order cryptic and lacking necessary analysis regarding inventive step. Consequently, the court allowed the appeal, setting aside the refusal and remanding the matter back to the Patent Office for fresh consideration.
Parle Elizabeth Tools Private Limited v.Pacific Tools Private Limited
The petitioners filed a petition seeking the revocation of patent number 420765, which was granted in favour of respondent no.1. The court allowed an application for exemption from filing copies and listed the main petition for further proceedings.
The Trustees Of Columbia University v.The Assistant Controller of Patents and Designs
The appellant challenged an order rejecting its amended patent claims (1-19) for 'METHODS AND COMPOSITIONS FOR TREATMENT OF AMYLOID DEPOSITION DISEASES' under Section 59 of the Patents Act. The appellant argued that the amendments were supported by the complete specification, citing relevant case law. The High Court set aside the impugned order and remanded the matter for fresh reconsideration.
Shimadzu Corporation v.The Assistant Controller of Patents and Designs, The Patent Office
Shimadzu Corporation appealed an order rejecting its patent application (No. 201647043103), which concerned a surrogate biomarker for evaluating amyloid beta peptide accumulation. The rejection was based on Section 3(i) of the Patents Act, 1970, as it related to diagnostic methods. The High Court set aside the order and remanded the matter, finding that the appellants were prejudiced by not having access to a key judgment before the initial hearing.
Mr Abhishek Sharma & Anr. v.Assistant Controller Of Patents And Designs
The appellants appealed a decision by the Assistant Controller of Patents and Designs refusing their patent application (No. 202111053480). The subject matter related to 'black coloured wearing' and its alleged effects on human health, which the Controller rejected as non-technical and an abstract theory lacking scientific evidence. The High Court dismissed the appeal both on merits and due to the inordinate delay in filing.
Hamrish Kumar Rajakumar v.Indian Council of Medical Research (ICMR)
The appellant filed an RTI seeking comprehensive information from ICMR regarding the legal framework, ownership, and formalities associated with protecting a Clinical Outcome Assessment (COA) tool developed by undergraduate students. The Commission found that the PIO had disclosed available public domain information, but directed ICMR to provide the Appellant with its detailed Intellectual Property Policy for complete transparency.
Sebille Educations Pvt. Ltd. v.Nikita Dubey Rai
Sebille Educations Pvt. Ltd. filed a suit against Nikita Dubey Rai, alleging infringement of its registered trademark 'LITTLE EINSTEINS' and associated copyrights in the field of educational services. The plaintiffs sought permanent injunctions against the use of deceptively similar marks like 'LEARNING EINSTEINS'. However, both parties amicably settled their dispute through a joint memorandum of compromise dated February 6, 2025.
Jupeng Bio (Hk) Limited v.The Controller of Patents and Designs, Government of India
Jupeng Bio appealed an order rejecting its patent application for 'Control of Conductivity in Anaerobic Fermentation'. The appellant challenged the rejection, arguing that the prior art cited did not explicitly disclose all claimed elements (conductivity and SCU relationship), and that the reasons for rejection under Section 3(d) were unreasoned. The High Court found deficiencies in the respondent's reasoning regarding both novelty and Section 3(d) non-patentability.
Novartis Ag v.Cdymax (India) Pharma Private Limited
The plaintiffs seek a permanent injunction against the defendant for infringing their patent related to the compound Ribociclib, used in breast cancer treatment. The defendant allegedly started manufacturing and exporting the patented compound without authorization.
Caleb Suresh Motupalli v.Controller of Patents
The appellant challenged the Controller's order rejecting his patent application based on various grounds, including lack of enablement, ambiguity in claims, and non-patentability. The High Court examined these issues, concluding that the invention lacked a demonstrable technical effect and failed to meet statutory requirements.
United States Of America v.Softgel Healthcare Private Limited
The petitioners (United States of America and associated entities) filed petitions seeking execution of Letters Rogatory issued by a US District Court. The dispute concerns alleged infringement of the '441 Patent' related to VYNDAMAX® by generic versions submitted via ANDA applications. The court passed an order appointing a Local Commissioner and setting up protocols for evidence collection.
United States Of America v.Softgel Healthcare Private Limited
The petitioners (United States of America and associated entities) filed petitions seeking judicial assistance from the Madras High Court to execute Letters Rogatory issued by the United States District Court at Delaware. The dispute concerns alleged infringement of the '441 Patent' covering VYNDAMAX® by generic versions submitted via ANDA applications in the U.S.
Apex Laboratories Pvt. Ltd. v.Ethichem Biotech
Apex Laboratories Pvt. Ltd filed a suit against Ethichem Biotech and others, alleging infringement of its registered trademarks and copyright related to the product ZINCOVIT. The plaintiff sought permanent injunctions against using deceptively similar marks like ZINCOVITA and for passing off. Despite the initial claims of trademark and copyright violations, the parties ultimately reached an amicable settlement.
Amazon Technologies Inc. v.The Controller of Patents & Designs
Amazon Technologies Inc. appealed a decision by the Assistant Controller of Patents & Designs refusing to grant a patent for its invention (Application No. 5937/CHENP/2010). The appeal challenged the refusal on the ground that it lacked inventive step, arguing that the refusal order was non-speaking as it failed to provide reasons for how the cited prior art documents applied to the claimed invention.
Macleods Pharmaceuticals Ltd. v.The Controller Of Patents & Anr.
Macleods Pharmaceuticals Ltd. (Petitioner) filed a revocation petition against Indian Patent IN 243301, held by Boehringer Ingelheim Pharma GmbH & Co. KG (Respondent No. 2), concerning the anti-diabetic drug LINAGLIPTIN. The Respondent challenged the maintainability of the petition on grounds that it was filed after the patent expired and because invalidity had already been raised in an ongoing infringement suit. The Court dismissed these objections, holding that a revocation petition can be sustained even after the patent term expires.
M/S Fiitjee Ltd. v.Abhishek Sapra
M/S Fiitjee Ltd. challenged an arbitral award, alleging that Abhishek Sapra violated a Non-Disclosure Agreement (NDA) and service contract by diverting vital company information during his employment as Financial Controller. The petitioner sought damages for this breach. The Delhi District Court dismissed the petition, holding that the court cannot review the dispute on merits or set aside the award without finding patent illegality.
Gsp Crop Science Pvt. Ltd. v.General Crop Science Pvt. Ltd. & Anr.
The Delhi High Court addressed several interlocutory applications filed by the defendants/counter claimants. The court condoned a 57-day delay in filing the written statement and directed the numbering of the counter claim seeking revocation of the plaintiff's patent (IN 394568). Further directions were issued regarding discovery and placing sales figures on record.
Syngenta Limited And Anr. v.Gsp Crop Science Private Limited
The plaintiffs filed an application seeking a direction to the defendant to comply with the mutually agreed Terms of Reference (ToR) and provide access to specific documents shared under the ToR. The defendant opposed this, citing concerns over leakage of proprietary information and violation of Section 104A of the Patents Act. The Court ruled in favor of the plaintiffs, directing the defendant to supply the requested information while allowing redaction of supplier names.
Novartis Ag v.Natco Pharma Limited
The suit was filed by Novartis seeking permanent injunction against infringement of its patent IN'026. Natco Pharma sought leave to file an additional written statement, arguing that plaintiffs suppressed documents relating to a prior Divisional Application which led to the grant of the patent. The Court allowed the application, holding that Order VIII Rule 9 CPC grants wide discretion to allow such pleadings in the interest of justice.
Novartis Ag v.Natco Pharma Limited
The case was filed for a permanent injunction against NATCO PHARMA for infringing on Novartis's Indian Patent No. 233161. The parties reached an amicable settlement during the proceedings.
M/s.Haldor Topsoe A/S v.Controller of Patents & Designs, Government of India
The petitioner challenged an order dated 09.03.2021 rejecting/abandoning their patent application (No. 297/CHE/2012). The petitioner argued that the rejection violated natural justice and was based on non-application of mind, as no proper second examination report was conducted. The Court found the order unsustainable due to violation of principles of natural justice and quashed it, remitting the matter for fresh consideration.
Italfarmaco Spa v.Deputy Controller Of Patents & Designs
Italfarmaco Spa appealed the rejection of its patent application for a method involving iron (III) caseinsuccinylate. The Deputy Controller rejected the grant on the grounds that the claimed invention lacked inventive step and fell under Section 3(d) of the Patents Act, 1970. The High Court upheld the respondent's decision.
Hindustan Aeronautics Limited v.Commissioner of Central Excise Bangalore - I
The appeal challenged the imposition of service tax under the 'Intellectual Property Right' category on payments made by HAL to BAE System for technical knowhow and assistance related to aircraft manufacturing. The Tribunal ruled that since the contract involved a temporary transfer of technology, it did not fall under the definition of IPR services chargeable to service tax.
Gilead Sciences Inc. v.Union of India
Gilead Sciences Inc. challenged a hearing notice and subsequent opposition board recommendation related to Indian Patent No.319927, arguing that the process violated The Patents Act, 1970 by not allowing them to present evidence. The Court quashed the impugned notices and recommendations.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.